Zhifei Biological Expands Vaccine Partnership with Merck
02:55 EDT 9 Jun 2012 | ChinaBio Today
Chongqing Zhifei Biological Products and Merck signed an MOU that expands the existing partnership between the two companies by entrusting Zhifei with the responsibility for China marketing of Merck’s RotaTeq, an oral pentavalent live rotavir..
Original Article: Zhifei Biological Expands Vaccine Partnership with Merck
More From BioPortfolio on "Zhifei Biological Expands Vaccine Partnership with Merck"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
